1. Home
  2. NHC vs MDXG Comparison

NHC vs MDXG Comparison

Compare NHC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NHC
  • MDXG
  • Stock Information
  • Founded
  • NHC 1971
  • MDXG 2006
  • Country
  • NHC United States
  • MDXG United States
  • Employees
  • NHC N/A
  • MDXG N/A
  • Industry
  • NHC Hospital/Nursing Management
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • NHC Health Care
  • MDXG Health Care
  • Exchange
  • NHC Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • NHC 1.6B
  • MDXG 1.3B
  • IPO Year
  • NHC N/A
  • MDXG N/A
  • Fundamental
  • Price
  • NHC $93.48
  • MDXG $7.98
  • Analyst Decision
  • NHC
  • MDXG Strong Buy
  • Analyst Count
  • NHC 0
  • MDXG 5
  • Target Price
  • NHC N/A
  • MDXG $12.00
  • AVG Volume (30 Days)
  • NHC 52.3K
  • MDXG 493.9K
  • Earning Date
  • NHC 02-28-2025
  • MDXG 02-26-2025
  • Dividend Yield
  • NHC 2.60%
  • MDXG N/A
  • EPS Growth
  • NHC 174.32
  • MDXG N/A
  • EPS
  • NHC 7.98
  • MDXG 0.52
  • Revenue
  • NHC $1,223,271,000.00
  • MDXG $342,804,000.00
  • Revenue This Year
  • NHC N/A
  • MDXG $9.56
  • Revenue Next Year
  • NHC N/A
  • MDXG $9.19
  • P/E Ratio
  • NHC $12.07
  • MDXG $15.14
  • Revenue Growth
  • NHC 10.74
  • MDXG 10.93
  • 52 Week Low
  • NHC $87.03
  • MDXG $5.47
  • 52 Week High
  • NHC $138.49
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • NHC 32.27
  • MDXG 35.32
  • Support Level
  • NHC $99.44
  • MDXG $7.81
  • Resistance Level
  • NHC $104.54
  • MDXG $8.54
  • Average True Range (ATR)
  • NHC 2.52
  • MDXG 0.23
  • MACD
  • NHC -0.18
  • MDXG -0.05
  • Stochastic Oscillator
  • NHC 3.19
  • MDXG 18.09

About NHC National HealthCare Corporation

National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: